u/dario_petrescu

The wider-market rows in the directory carry a band and a report count and nothing else, deliberately.

Would qualify this slightly. Fewer entries means less sampling, and less sampling is not the same as a worse process.

Yes. Spread across lots is the number that tells you about the process. A single high result tells you about a vial.

Correcting myself upthread: the criterion I quoted was updated for this year.

The variation between pharmacies inside my own country was larger than the variation I had been chasing across the border.

Is this a cross-border question or a domestic one?

Kept a spreadsheet of quoted versus actual lead time across 13 orders. The quoted number held.

Cosigning on lot matching. It sounds trivial and it predicts almost everything else about how an operation is run.

no referral links, no affiliate links, not once

I would not treat a two-kilo range as drift requiring action. That is ordinary weight variation.

Cosigning on lot matching. It sounds trivial and it predicts almost everything else about how an operation is run.

Disagree that reviews are worthless. They are worthless when they say "fast shipping A+++". A dated one naming a compound and a document is evidence.

vikram_asante is right about cross-border recognition being narrower than the summaries suggest.

This is the split the whole board depends on. Authorisation is European; payment is national.

Yes, and the reason the wider-market table has no scores is that a score built on two reports would be a lie with a decimal point.

registration number, then everything else

Mild pushback: a supplier with fewer entries is not worse, it is less sampled.

kasper_cabrera is describing the batch record test and it is the fastest signal available before you spend anything.

I would not treat a two-kilo range as drift requiring action. That is ordinary weight variation.

reship policy in writing before the order, not after

Agree. The verification log is the part with the checkable facts in it; the number at the top is just a summary of a lot of averaging.

Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.

This is the split the whole board depends on. Authorisation is European; payment is national.

Checked the sponsor disclosure because I assumed it would be vague. It was extremely specific and slightly boring.

buy small first, test it, then decide

Agreed. Publishing the ranking formula is the difference between a feed and a black box, and it costs nothing to do.

This. Ask for the batch record. The ones who send it inside a day have told you more than any review could.

the trials that looked at withdrawal are unambiguous about what follows

Moderation of individual cases happens in modmail rather than in threads, because a public discussion of one person’s removal is worse for that person than a private one.

Right, and a shortage notice in one country tells you very little about the next one along.

pack sizes differ, so per-month comparisons need care

Pack sizes and presentations differ between member states, so a headline price is not comparable until it is normalised to a common quantity.

a directory entry is a record, not a recommendation

Yes. The habits have to outlive the dose or the maintenance phase is just a countdown.

Cross-border prescription recognition exists under EU rules but is conditional and narrower than commonly assumed, with requirements about the prescription’s form and content.

I would separate documentation from logistics. A supplier can be excellent at one and ordinary at the other, and averaging them hides it.

Not convinced by the ranking-by-vibe approach here. The community number is derived from reports; your feeling is derived from four posts you remember.

Agree.

Would qualify this slightly. Fewer entries means less sampling, and less sampling is not the same as a worse process.

Apotheke pricing and pharmacy pricing elsewhere are different systems

Adding the practical step — read your own country’s published criteria. They exist and they are definitive.

I would not archive earlier. The old threads are the most-searched thing on the site.

nobody here is paid, including the moderators

no referral links, no affiliate links, not once

Maintenance is the phase with the least published guidance and the most individual variation, which is precisely why board consensus here is worth less than usual.

This. The withdrawal data is not ambiguous and framing regain as a personal failure is both wrong and cruel.